MYRIAD GENETICS, INC. Share Repurchase Authorization
MYRIAD GENETICS, INC. (MYGN) had Share Repurchase Authorization of $200.00 million as of 2016-06-30, per its 10-Q filed 2023-11-07.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramAuthorizedAmount1 · last filed 2023-11-07
- 2016-06-30: Stock Repurchase Program, Authorized Amount $200.00M.
- 2015-02-28: Stock Repurchase Program, Authorized Amount $1.20B.
- 2014-06-30: Stock Repurchase Program, Authorized Amount $1.00B.
- 2013-11-30: Stock Repurchase Program, Authorized Amount $300.00M.
| Period end | Stock Repurchase Program, Authorized Amount |
|---|---|
| 2016-06-30 | $200.00M 10-Q · filed 2023-11-07 |
| 2015-02-28 | $1.20B 10-Q · filed 2015-05-06 |
| 2014-06-30 | $1.00B 10-K · filed 2014-08-13 |
| 2013-11-30 | $300.00M 10-K · filed 2014-08-13 |
| 2013-02-28 | $200.00M 10-K · filed 2014-08-13 |
| 2011-08-31 | $200.00M 10-K · filed 2014-08-13 |
| 2011-03-31 | $100.00M 10-K · filed 2014-08-13 |
| 2010-08-31 | $100.00M 10-K · filed 2014-08-13 |
| 2010-05-31 | $100.00M 10-K · filed 2014-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |